Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and prolonged stable disease observed in adenocarcinoma Meeting Abstract
| Authors: | Ku, G. Y.; Janjigian, Y. Y.; Shah, M. A.; Herrera, J.; Tang, L. H.; Fuqua, L.; Capanu, M.; Ilson, D. |
| Abstract Title: | Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and prolonged stable disease observed in adenocarcinoma |
| Meeting Title: | 2013 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2013 Jan 24-26 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-02-01 |
| Language: | English |
| ACCESSION: | WOS:000333679000093 |
| DOI: | 10.1200/jco.2013.31.4_suppl.91 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 91 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
